Leads Biolabs gets six studies selected for ESMO 2026
July 14, 2026 | 11:39
Nanjing Leads Biolabs, listed under stock code 9887.HK, announced six of its latest research studies were accepted for presentation at the 2026 European Society for Medical Oncology congress.
Mobile Version